11/25/2024
8:00 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:59 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:46 AM | Deep Track Capital, LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
3:55 PM | MORGAN STANLEY (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
3:11 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 424B5 | |
11/04/2024
12:55 PM | Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024
7:36 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
10/31/2024
7:41 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 424B5 | |
10/31/2024
7:05 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
10:59 AM | STATE STREET CORP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
10/04/2024
6:15 PM | LYONS GARY A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
7:38 PM | Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:22 PM | Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
5:29 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:05 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
9:54 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
9:34 AM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
9:35 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
8:30 PM | Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:24 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form S-3ASR | |
08/01/2024
3:40 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
3:46 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
3:35 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form ARS | |
03/27/2024
3:31 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024
3:31 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024
3:33 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form DEFA14A | |
02/20/2024
7:10 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
1:35 PM | ARMISTICE CAPITAL, LLC (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
5:38 AM | MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
9:33 AM | MORGAN STANLEY (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G | |
02/07/2024
6:37 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
02/01/2024
8:57 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
8:58 PM | Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
8:58 PM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Could this be the hottest crypto discovery of all time? (Ad) I want to let you in on what may be the hottest crypto discovery of all time…
One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter.
Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time
It sounds nuts… trust me I know that…
But just as I would hate for you to jump into any risky crypto asset…
That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024.
Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free… If you want in, Just Click Here |
02/01/2024
8:58 PM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
11:44 AM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
10:39 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
8:52 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/25/2024
8:24 AM | STATE STREET CORP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024
12:17 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
9:51 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
9:52 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
6:07 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:11 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
